BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 32736382)

  • 1. Clonal hematopoiesis and risk for hematologic malignancy.
    Warren JT; Link DC
    Blood; 2020 Oct; 136(14):1599-1605. PubMed ID: 32736382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal Hematopoiesis: Origins and determinants of evolution.
    Mendez LM; Patnaik MM
    Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.
    von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A
    Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal hematopoiesis and inflammation: A review of mechanisms and clinical implications.
    Nathan DI; Dougherty M; Bhatta M; Mascarenhas J; Marcellino BK
    Crit Rev Oncol Hematol; 2023 Dec; 192():104187. PubMed ID: 37879493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?
    Steensma DP
    Best Pract Res Clin Haematol; 2021 Dec; 34(4):101327. PubMed ID: 34865699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Insights from Studies of Clonal Hematopoiesis.
    Gibson CJ; Steensma DP
    Clin Cancer Res; 2018 Oct; 24(19):4633-4642. PubMed ID: 29703819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer.
    Stonestrom AJ; Menghrajani KN; Devlin SM; Franch-Expósito S; Ptashkin RN; Patel SY; Spitzer B; Wu X; Jee J; Sánchez Vela P; Milbank JH; Shah RH; Mohanty AS; Brannon AR; Xiao W; Berger MF; Mantha S; Levine RL
    Blood Adv; 2024 Feb; 8(4):846-856. PubMed ID: 38147626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms.
    Xie Z; Chen EC; Mendez LM; Komrokji R; Zeidan AM
    Cancer J; 2023 May-Jun 01; 29(3):130-137. PubMed ID: 37195768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal Hematopoiesis and risk of Acute Myeloid Leukemia.
    Desai P; Hassane D; Roboz GJ
    Best Pract Res Clin Haematol; 2019 Jun; 32(2):177-185. PubMed ID: 31203999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal hematopoiesis in the inherited bone marrow failure syndromes.
    Tsai FD; Lindsley RC
    Blood; 2020 Oct; 136(14):1615-1622. PubMed ID: 32736377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities.
    Younes IE; Syler L; Hamed A
    Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Origin of Clonal Hematopoiesis and Its Implication in Human Diseases.
    Zhang Z; Sun J
    Adv Exp Med Biol; 2023; 1442():65-83. PubMed ID: 38228959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASXL1 mutation in clonal hematopoiesis.
    Fujino T; Kitamura T
    Exp Hematol; 2020 Mar; 83():74-84. PubMed ID: 31945396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta-analysis.
    Nowakowska MK; Kim T; Thompson MT; Bolton KL; Deswal A; Lin SH; Scheet P; Wehner MR; Nead KT
    Am J Hematol; 2022 Apr; 97(4):411-420. PubMed ID: 35015316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What to tell your patient with clonal hematopoiesis and why: insights from 2 specialized clinics.
    Steensma DP; Bolton KL
    Blood; 2020 Oct; 136(14):1623-1631. PubMed ID: 32736381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal hematopoiesis and nonhematologic disorders.
    Jaiswal S
    Blood; 2020 Oct; 136(14):1606-1614. PubMed ID: 32736379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal hematopoiesis: Molecular and clinical implications.
    Kusne Y; Xie Z; Patnaik MM
    Leuk Res; 2022 Feb; 113():106787. PubMed ID: 35091334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How low can you go?: Methodologic considerations in clonal hematopoiesis variant calling.
    Beeler JS; Bolton KL
    Leuk Res; 2023 Dec; 135():107419. PubMed ID: 37956474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies.
    Ye B; Sheng Y; Zhang M; Hu Y; Huang H
    Cancer Lett; 2022 Jul; 538():215691. PubMed ID: 35469959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic dysregulation of hematopoietic stem cells and preleukemic state.
    Kunimoto H; Nakajima H
    Int J Hematol; 2017 Jul; 106(1):34-44. PubMed ID: 28555413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.